These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24602606)

  • 1. Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation.
    Aguilar EC; Leonel AJ; Teixeira LG; Silva AR; Silva JF; Pelaez JM; Capettini LS; Lemos VS; Santos RA; Alvarez-Leite JI
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):606-13. PubMed ID: 24602606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism involving NADPH oxidase down-regulation in endothelial cells.
    Aguilar EC; Santos LC; Leonel AJ; de Oliveira JS; Santos EA; Navia-Pelaez JM; da Silva JF; Mendes BP; Capettini LS; Teixeira LG; Lemos VS; Alvarez-Leite JI
    J Nutr Biochem; 2016 Aug; 34():99-105. PubMed ID: 27261536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Lu Z; Zhang X; Li Y; Jin J; Huang Y
    J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.
    Harb D; Bujold K; Febbraio M; Sirois MG; Ong H; Marleau S
    Cardiovasc Res; 2009 Jul; 83(1):42-51. PubMed ID: 19264766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extract from medical leech improve the function of endothelial cells in vitro and attenuates atherosclerosis in ApoE null mice by reducing macrophages in the lesions.
    Wang Y; Zhao X; Wang YS; Song SL; Liang H; Ji AG
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):119-25. PubMed ID: 25450702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
    Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo.
    Akhmedov A; Rozenberg I; Paneni F; Camici GG; Shi Y; Doerries C; Sledzinska A; Mocharla P; Breitenstein A; Lohmann C; Stein S; von Lukowicz T; Kurrer MO; Borén J; Becher B; Tanner FC; Landmesser U; Matter CM; Lüscher TF
    Eur Heart J; 2014 Oct; 35(40):2839-48. PubMed ID: 24419805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
    Mallavia B; Recio C; Oguiza A; Ortiz-Muñoz G; Lazaro I; Lopez-Parra V; Lopez-Franco O; Schindler S; Depping R; Egido J; Gomez-Guerrero C
    Am J Pathol; 2013 May; 182(5):1910-21. PubMed ID: 23597852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability.
    Calder PC
    Mol Nutr Food Res; 2012 Jul; 56(7):1073-80. PubMed ID: 22760980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
    Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
    Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sesamin attenuates intercellular cell adhesion molecule-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in apolipoprotein-E-deficient mice.
    Wu WH; Wang SH; Kuan II; Kao YS; Wu PJ; Liang CJ; Chien HF; Kao CH; Huang CJ; Chen YL
    Mol Nutr Food Res; 2010 Sep; 54(9):1340-50. PubMed ID: 20306475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
    Romeo GR; Moulton KS; Kazlauskas A
    Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice.
    Cipriani S; Francisci D; Mencarelli A; Renga B; Schiaroli E; D'Amore C; Baldelli F; Fiorucci S
    Circulation; 2013 May; 127(21):2114-24. PubMed ID: 23633271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
    Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
    Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.